AstraZeneca announced new phase III clinical data for baxdrostat, an investigational, first-in-class, oral aldosterone synthase inhibitor being studied for patients with uncontrolled or resistant ...
Neurophos is developing a massive optical systolic array clocked at 56GHz good for 470 petaFLOPS of FP4 compute As Moore's ...
Interim results indicate NS002 demonstrated significantly faster absorption and higher peak epinephrine levels compared to ...
This article originally appeared in the National Association of EMS Physicians blog and is reprinted here with permission. By ...
Interim results indicate NS002 demonstrated significantly faster absorption and higher peak epinephrine levels compared to EpiPen 91% of study participants achieved the 100 pg/ml plasma threshold at ...
Duchenne: Dosed 33 participants in the Phase 1/2 INSPIRE DUCHENNE clinical trial as of January 9, 2026; SGT-003 continues to be generally well ...
Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease ...
Primary aldosteronism management depends on a multitude of factors, and surgical adrenalectomy is generally recommended in unilateral disease.
Background Cardiogenic shock (CS) complicating acute myocardial infarction (AMI) carries high mortality. Early ...
Background Patients with severe aortic stenosis (AS) are at high risk of mortality, regardless of symptom status. Despite ...
W H O’s Global HEARTS is the largest worldwide effort to improve hypertension control through standardised care. HEARTS in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results